HCG: Device, Neurovascular Embolization

Product code HCG, “Device, Neurovascular Embolization” in FDA's classification database, is a Class II device type under 21 CFR 882.5950 (neurovascular embolization device), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 187 clearances under HCG, 73 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
HCG
Regulation
21 CFR 882.5950
Class
II
Panel
Neurology
Clearances
187
Most recent
Aug 14, 2026
Median review, last 2 years
30 days
Third-party review
Not eligible
Implant
Yes

What it covers

A neurovascular embolization device is an intravascular implant intended to permanently occlude blood flow to cerebral aneurysms and cerebral ateriovenous malformations. This does not include cyanoacrylates and other embolic agents, which act by polymerization or precipitation. Embolization devices used in other vascular applications are also not included in this classification, see § 870.3300.

The identification in 21 CFR 882.5950, neurovascular embolization device. FDA gives HCG no definition of its own, so the regulation’s describes it.

FDA flags HCG devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K262419MICRUSFRAME (MFR100202); MICRUSFRAME (MFR100253); MICRUSFRAME (MFR100305); MICRUSFRAME (MFR100356); MICRUSFRAME (MFR100407); MICRUSFRAME (MFR100412); MICRUSFRAME (MFR100509); MICRUSFRAME (MFR100517); MICRUSFRAME (MFR100611); MICRUSFRAME (MFR100626); MICRUSFRAME (MFR100713); MICRUSFRAME (MFR100730); MICRUSFRAME (MFR100816); MICRUSFRAME (MFR100829); MICRUSFRAME (MFR140225); MICRUSFRAME (MFR140303); MICRUSFRAME (MFR140304); MICRUSFRAME (MFR140306); MICRUSFRAME (MFR140406); MICRUSFRAME (MFCerenovus, Inc.Aug 14, 2026Special
K261772Target Xtra Detachable CoilStryker NeurovscularJun 24, 2026Special
K260351Numen™ Helia Coil Embolization System; NumenFR™ Detachment SystemMicroPort NeuroTech (Shanghai) Co., Ltd.May 20, 2026Special
K254221Optima Coil System (OptiOne Coil System)Balt USA, LLCJan 27, 2026Special
K252694Target Detachable CoilStryker NeurovascularDec 11, 2025Traditional
K251832InZone IST Detachment System; IZDS Connecting CableStryker NeurovascularOct 17, 2025Special
K252700Optima Coil System (Optima Packing Coil System)Balt USA, LLCSep 26, 2025Special
K242154Numen™ Coil Embolization System; NumenFR™ Detachment SystemMicroPort NeuroTech (Shanghai) Co., Ltd.Sep 30, 2024Special
K242582Optima Coil System (OptiBlock Line Extension)Balt USA, LLCSep 27, 2024Special
K242243Target Detachable CoilsStryker NeurovscularAug 29, 2024Special
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 187 with a free account)

Clearances by year

73 HCG 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)430
20253107
2024449
20232147
20223114
20215103
20202147
2019130
20184173
2017597
2016737
2015560
2014566
2013767
2012730
2011978

Who submits

20 applicants cleared a HCG device since 2011. 92% of the clearances went to applicants in United States, then China (5%) and Switzerland (3%). By type: Special 67% and Traditional 33%.

ApplicantClearances since 2011
MicroVention, Inc.13
Stryker Neurovascular11
Penumbra, Inc.10
Blockade Medical6
Codman & Shurtleff, Inc.6
Balt USA, LLC5
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular4
MicroPort NeuroTech (Shanghai) Co., Ltd.4

How FDA classifies it

Class II (special controls.) The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Vascular and Neurovascular Embolization Devices.” For availability of this guidance document, see § 882.1(e).

From 21 CFR 882.5950. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 882.5950 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent HCG clearances declared.

Ask about HCG

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about HCG

What is FDA product code HCG?

Product code HCG, “Device, Neurovascular Embolization” in FDA's classification database, is a Class II device type under 21 CFR 882.5950 (neurovascular embolization device), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 187 clearances under HCG, 73 of them since 2011.

How many 510(k) clearances are there under HCG?

FDA’s 510(k) database listed 187 clearances under HCG as of Oct 29, 2026, 73 of them decided since 2011; the most recent decision was Aug 14, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a HCG 510(k)?

For the 7 HCG clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 30 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most HCG clearances?

Since 2011: MicroVention, Inc. (13), Stryker Neurovascular (11), Penumbra, Inc. (10), Blockade Medical (6) and Codman & Shurtleff, Inc. (6). 20 applicants have cleared a HCG device in that time.

Sources

  1. FDA product classification: HCG · Product Classification database
  2. 21 CFR 882.5950: Neurovascular embolization device · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for HCG · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow HCGGet an email when FDA clears, recalls or publishes guidance for HCG devices.

Know what FDA already cleared.